NISA INVESTMENT ADVISORS, LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 100 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,039
+2431.8%
656
+1722.2%
0.00%
Q2 2023$594
-99.8%
36
-99.8%
0.00%
-100.0%
Q1 2022$270,000
+900.0%
23,400
+550.0%
0.00%
Q4 2021$27,000
+285.7%
3,600
+554.5%
0.00%
Q3 2021$7,000
-36.4%
5500.0%0.00%
Q2 2021$11,000
-8.3%
5500.0%0.00%
Q1 2021$12,000
-25.0%
5500.0%0.00%
Q4 2020$16,000
-61.0%
550
-71.1%
0.00%
Q3 2020$41,0001,9000.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders